ACH
ONC

ArrowMark Colorado Holdings’s BeOne Medicines Ltd ONC Stock Holding History

ArrowMark Colorado Holdings’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-47,000
Closed -$1.38M – 283
2016
Q1 		$1.38M Buy
+47,000
New +$1.33M 0.03% 204

Other funds holding ONC

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
HIM
Hillhouse Investment Management Grand Cayman, Cayman Islands $3.13B AUM 7.29% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
QF
QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

ArrowMark Colorado Holdings's ONC Position: Q2 2016 in Review

ArrowMark Colorado Holdings sold out of BeOne Medicines Ltd (ONC) in Q2 2016, closing a stake of 47,000 shares — an estimated $1.38M sold.

ArrowMark Colorado Holdings first reported a position in ONC in Q1 2016 and held it in 1 quarter. The position peaked at $1.38M in Q1 2016. 39 funds tracked by Wall St. Rank hold ONC as of Q2 2016.

  • ArrowMark Colorado Holdings reported no remaining BeOne Medicines Ltd position as of Q2 2016 after selling out during the quarter.
  • ArrowMark Colorado Holdings sold 47,000 BeOne Medicines Ltd shares in Q2 2016, an estimated $1.38M.
  • ArrowMark Colorado Holdings first reported a position in BeOne Medicines Ltd in Q1 2016 and held it in 1 quarter.
  • ArrowMark Colorado Holdings's BeOne Medicines Ltd position peaked at $1.38M in Q1 2016.
  • 39 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2016.

Based on ArrowMark Colorado Holdings's 13F filing for Q2 2016, filed 15 Aug 2016.